ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $4.65M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 7 sales

ROTHBLATT MARTINE A

Filed: 9/8/2026ACC: 0001106578-26-000136

InsiderROTHBLATT MARTINE ACIK 1106578

→

IssuerUNITED THERAPEUTICS CORPCIK 1082554

DirectorOfficer· Chairperson & CEO

Since Mar 2026

-9.50K

Net shares

Net seller

$4.65M

Total sold

Open market trades

0B · 7S

Total transactions

9.50K acquired · 19K disposed

Non-Derivative Transactions8

Common Stock

Indirect

M · Option Exercise

+9.50K

Price / share

$117.76

Trade value

$1.12M

% of position

2.9%

9/4/2026

324.44K→333.94K

Common Stock

Indirect

S · Sale

−40.00

Price / share

$485.85

Trade value

$19.43K

% of position

0.0%

9/4/2026

333.94K→333.90K

Common Stock

Indirect

S · Sale

−223.00

Price / share

$486.88

Trade value

$108.57K

% of position

0.1%

9/4/2026

333.90K→333.68K

Common Stock

Indirect

S · Sale

−2.82K

Price / share

$488.08

Trade value

$1.38M

% of position

0.8%

9/4/2026

333.68K→330.86K

Common Stock

Indirect

S · Sale

−3.42K

Price / share

$489.12

Trade value

$1.68M

% of position

1.0%

9/4/2026

330.86K→327.44K

Common Stock

Indirect

S · Sale

−1.51K

Price / share

$490.01

Trade value

$741.87K

% of position

0.5%

9/4/2026

327.44K→325.92K

Common Stock

Indirect

S · Sale

−1.16K

Price / share

$490.94

Trade value

$569.48K

% of position

0.4%

9/4/2026

325.92K→324.76K

Common Stock

Indirect

S · Sale

−320.00

Price / share

$491.69

Trade value

$157.34K

% of position

0.1%

9/4/2026

324.76K→324.44K

Total

Net shares

+0.00

Net value

-$3.53M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	9/4/2026	M · Option Exercise	+9.50K	$117.76	$1.12M	2.9%	324.44K	333.94K
Common Stock Indirect	9/4/2026	S · Sale	−40.00	$485.85	$19.43K	0.0%	333.94K	333.90K
Common Stock Indirect	9/4/2026	S · Sale	−223.00	$486.88	$108.57K	0.1%	333.90K	333.68K
Common Stock Indirect	9/4/2026	S · Sale	−2.82K	$488.08	$1.38M	0.8%	333.68K	330.86K
Common Stock Indirect	9/4/2026	S · Sale	−3.42K	$489.12	$1.68M	1.0%	330.86K	327.44K
Common Stock Indirect	9/4/2026	S · Sale	−1.51K	$490.01	$741.87K	0.5%	327.44K	325.92K
Common Stock Indirect	9/4/2026	S · Sale	−1.16K	$490.94	$569.48K	0.4%	325.92K	324.76K
Common Stock Indirect	9/4/2026	S · Sale	−320.00	$491.69	$157.34K	0.1%	324.76K	324.44K
Total			+0.00		-$3.53M

Derivative Transactions1

Stock Option

Indirect

M · Option Exercise

Converts to

Common Stock

9.50K shares

−9.50K

Strike price

117.76

Held after

489.91K

Exercisable

—

9/4/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option Indirect	Common Stock9.50K shares	9/4/2026	M · Option Exercise	−9.50K	117.76	—	489.91K

Non-Derivative Holdings (Post-Transaction)5

Common Stock

Indirect

Shares owned8.90K

Common Stock

Direct

Shares owned40.51K

Common Stock

Indirect

Shares owned249.11K

Common Stock

Indirect

Shares owned45.60K

Common Stock

Indirect

Shares owned166.00

Total

40.51K direct·303.77K indirect344.29K

Security Title	Shares Owned	Ownership Type
Common Stock	8.90K	Indirect
Common Stock	40.51K	Direct
Common Stock	249.11K	Indirect
Common Stock	45.60K	Indirect
Common Stock	166.00	Indirect
Total	344.29K	40.51K direct·303.77K indirect

Derivative Holdings (Post-Transaction)0

No derivative holdings reported